WDR23 regulates NRF2 independently of KEAP1.
WDR23 regulates NRF2 independently of KEAP1.
复制标题
DOI:
10.1371/journal.pgen.1006762
复制
发表时间:
2017-04
期刊:
影响因子:
4.5
通讯作者:
Curran SP
中科院分区:
文献类型:
--
作者:
Lo JY;Spatola BN;Curran SP
Cellular adaptation to stress is essential to ensure organismal survival. NRF2/NFE2L2 is a key determinant of xenobiotic stress responses, and loss of negative regulation by the KEAP1-CUL3 proteasome system is implicated in several chemo- and radiation-resistant cancers. Advantageously using C. elegans alongside human cell culture models, we establish a new WDR23-DDB1-CUL4 regulatory axis for NRF2 activity that operates independently of the canonical KEAP1-CUL3 system. WDR23 binds the DIDLID sequence within the Neh2 domain of NRF2 to regulate its stability; this regulation is not dependent on the KEAP1-binding DLG or ETGE motifs. The C-terminal domain of WDR23 is highly conserved and involved in regulation of NRF2 by the DDB1-CUL4 complex. The addition of WDR23 increases cellular sensitivity to cytotoxic chemotherapeutic drugs and suppresses NRF2 in KEAP1-negative cancer cell lines. Together, our results identify WDR23 as an alternative regulator of NRF2 proteostasis and uncover a cellular pathway that regulates NRF2 activity and capacity for cytoprotection independently of KEAP1. Chronic exposure to environmental stressors throughout life (“the exposome”) has been tied to several cancers in humans. Cellular adaptation to stress is essential to ensure organismal survival, and NRF2 is an exceptionally well-studied and key determinant of cellular stress responses that plays complex roles in cancer biology and responses to xenobiotics, including chemotherapies. Our studies have established a functional and evolutionarily conserved role for WDR23 as a substrate receptor for the Cullin4(CUL4)-DDB1 E3-ubiquitin ligase, which regulates NRF2 protein levels and activity, and which operates independently of the canonical KEAP1-CUL3 pathway. KEAP1 has been the most highly studied regulator of NRF2, as mutations in KEAP1, which result in uncontrolled activation of NRF2 and chemo-resistance, are found in many aggressive cancers. Importantly, increased expression of WDR23 in KEAP1(-/-) cancer cells restores aberrant NRF2 regulation. In the absence of a KEAP1-like system, C. elegans WDR-23 has been shown to regulate the worm cytoprotective transcription factor SKN-1. We have leveraged C. elegans genetic approaches to identify conserved regulatory mechanisms of mammalian cytoprotection by NRF2. Collectively, our studies suggest control of NRF2 homeostasis is much more sophisticated than previously appreciated.